APO Research
Talk to an analyst

APO RESEARCH · REPORT

Leukocyte Surface Antigen CD47

Compare research editions
View pricing & licenses

Selected research

Market Analysis & Forecast

Global Leukocyte Surface Antigen CD47 Market Analysis and Forecast 2026-2032

22 December 2025192 pages

Choose your research edition.

Industry ResearchLeukocyte Surface Antigen CD47 Industry Research Report 2026124 pages · $2,950 USDIndustry Growth & TrendsGlobal Leukocyte Surface Antigen CD47 Industry Growth and Trends Forecast to 203291 pages · $3,450 USDMarket StructureGlobal Leukocyte Surface Antigen CD47 Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032182 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Leukocyte Surface Antigen CD47 Market Outlook and Growth Opportunities 2026192 pages · $4,250 USDMarket Analysis & ForecastGlobal Leukocyte Surface Antigen CD47 Market Analysis and Forecast 2026-2032192 pages · $4,950 USD

Market perspective

The global Leukocyte Surface Antigen CD47 market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The US & Canada market for Leukocyte Surface Antigen CD47 is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Europe market for Leukocyte Surface Antigen CD47 is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Read the full market overview

Asia-Pacific market for Leukocyte Surface Antigen CD47 is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The China market for Leukocyte Surface Antigen CD47 is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The major global manufacturers of Leukocyte Surface Antigen CD47 include Trillium Therapeutics Inc, Surface Oncology Inc, Forty Seven Inc, Celgene Corp and Aurigene Discovery Technologies Ltd, etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.

This report presents an overview of global market for Leukocyte Surface Antigen CD47, sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of Leukocyte Surface Antigen CD47, also provides the sales of main regions and countries. Of the upcoming market potential for Leukocyte Surface Antigen CD47, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Leukocyte Surface Antigen CD47 sales, revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Leukocyte Surface Antigen CD47 market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2021 to 2032. Evaluation and forecast the market size for Leukocyte Surface Antigen CD47 sales, projected growth trends, production technology, application and end-user industry.

Leukocyte Surface Antigen CD47 Segment by Company

Trillium Therapeutics Inc

Surface Oncology Inc

Forty Seven Inc

Celgene Corp

Aurigene Discovery Technologies Ltd

Leukocyte Surface Antigen CD47 Segment by Type

PSTx-23

CC-90002

B-6H12

ALX-148

Others

Leukocyte Surface Antigen CD47 Segment by Application

Ischemia Reperfusion Injury

Kindney Transplant Rejection

Ovarian Cancer

Lymphoma

Others

Leukocyte Surface Antigen CD47 Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Leukocyte Surface Antigen CD47 market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Leukocyte Surface Antigen CD47 and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Leukocyte Surface Antigen CD47.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type and by application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Sales (consumption), revenue of Leukocyte Surface Antigen CD47 in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.

Chapter 4: Detailed analysis of Leukocyte Surface Antigen CD47 manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Leukocyte Surface Antigen CD47 sales, revenue, price, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, sales, and revenue for each segment.

Chapter 9: Europe by type, by application and by country, sales, and revenue for each segment.

Chapter 10: China type, by application, sales, and revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, sales, and revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, sales, and revenue for each segment.

Chapter 13: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.

Chapter 14: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Leukocyte Surface Antigen CD47 Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. PSTx-23 Major Manufacturers Table 3. CC-90002 Major Manufacturers Table 4. B-6H12 Major Manufacturers Table 5. ALX-148 Major Manufacturers Table 6. Others Major Manufacturers Table 7. Global Leukocyte Surface Antigen CD47 Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 8. Ischemia Reperfusion Injury Major Manufacturers Table 9. Kindney Transplant Rejection Major Manufacturers Table 10. Ovarian Cancer Major Manufacturers Table 11. Lymphoma Major Manufacturers Table 12. Others Major Manufacturers Table 13. Leukocyte Surface Antigen CD47 Industry Trends Table 14. Leukocyte Surface Antigen CD47 Industry Drivers Table 15. Leukocyte Surface Antigen CD47 Industry Opportunities and Challenges Table 16. Leukocyte Surface Antigen CD47 Industry Restraints Table 17. Global Leukocyte Surface Antigen CD47 Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 18. Global Leukocyte Surface Antigen CD47 Revenue by Region (2021-2026) & (US$ Million) Table 19. Global Leukocyte Surface Antigen CD47 Revenue by Region (2027-2032) & (US$ Million) Table 20. Global Leukocyte Surface Antigen CD47 Revenue Market Share by Region (2021-2026) Table 21. Global Leukocyte Surface Antigen CD47 Revenue Market Share by Region (2027-2032) Table 22. Global Leukocyte Surface Antigen CD47 Sales Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (k units) Table 23. Global Leukocyte Surface Antigen CD47 Sales by Region (2021-2026) & (k units) Table 24. Global Leukocyte Surface Antigen CD47 Sales by Region (2027-2032) & (k units) Table 25. Global Leukocyte Surface Antigen CD47 Sales Market Share by Region (2021-2026) Table 26. Global Leukocyte Surface Antigen CD47 Sales Market Share by Region (2027-2032) Table 27. Global Leukocyte Surface Antigen CD47 Revenue by Manufacturers (US$ Million) & (2021-2026) Table 28. Global Leukocyte Surface Antigen CD47 Revenue Market Share by Manufacturers (2021-2026) Table 29. Global Leukocyte Surface Antigen CD47 Sales by Manufacturers (US$ Million) & (2021-2026) Table 30. Global Leukocyte Surface Antigen CD47 Sales Market Share by Manufacturers (2021-2026) Table 31. Global Leukocyte Surface Antigen CD47 Sales Price (US$/unit) of Manufacturers (2021-2026) Table 32. Global Leukocyte Surface Antigen CD47 Key Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 33. Global Leukocyte Surface Antigen CD47 Key Manufacturers Manufacturing Sites & Headquarters Table 34. Global Leukocyte Surface Antigen CD47 Manufacturers, Product Type & Application Table 35. Global Leukocyte Surface Antigen CD47 Manufacturers' Establishment Date Table 36. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 37. Global Leukocyte Surface Antigen CD47 by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 38. Global Leukocyte Surface Antigen CD47 Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 39. Global Leukocyte Surface Antigen CD47 Revenue by Type (2021-2026) & (US$ Million) Table 40. Global Leukocyte Surface Antigen CD47 Revenue by Type (2027-2032) & (US$ Million) Table 41. Global Leukocyte Surface Antigen CD47 Revenue Market Share by Type (2021-2026) Table 42. Global Leukocyte Surface Antigen CD47 Revenue Market Share by Type (2027-2032) Table 43. Global Leukocyte Surface Antigen CD47 Sales by Type 2021 VS 2025 VS 2032 (k units) Table 44. Global Leukocyte Surface Antigen CD47 Sales by Type (2021-2026) & (k units) Table 45. Global Leukocyte Surface Antigen CD47 Sales by Type (2027-2032) & (k units) Table 46. Global Leukocyte Surface Antigen CD47 Sales Market Share by Type (2021-2026) Table 47. Global Leukocyte Surface Antigen CD47 Sales Market Share by Type (2027-2032) Table 48. Global Leukocyte Surface Antigen CD47 Price by Type (2021-2026) & (US$/unit) Table 49. Global Leukocyte Surface Antigen CD47 Price by Type (2027-2032) & (US$/unit) Table 50. Global Leukocyte Surface Antigen CD47 Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 51. Global Leukocyte Surface Antigen CD47 Revenue by Application (2021-2026) & (US$ Million) Table 52. Global Leukocyte Surface Antigen CD47 Revenue by Application (2027-2032) & (US$ Million) Table 53. Global Leukocyte Surface Antigen CD47 Revenue Market Share by Application (2021-2026) Table 54. Global Leukocyte Surface Antigen CD47 Revenue Market Share by Application (2027-2032) Table 55. Global Leukocyte Surface Antigen CD47 Sales by Application 2021 VS 2025 VS 2032 (k units) Table 56. Global Leukocyte Surface Antigen CD47 Sales by Application (2021-2026) & (k units) Table 57. Global Leukocyte Surface Antigen CD47 Sales by Application (2027-2032) & (k units) Table 58. Global Leukocyte Surface Antigen CD47 Sales Market Share by Application (2021-2026) Table 59. Global Leukocyte Surface Antigen CD47 Sales Market Share by Application (2027-2032) Table 60. Global Leukocyte Surface Antigen CD47 Price by Application (2021-2026) & (US$/unit) Table 61. Global Leukocyte Surface Antigen CD47 Price by Application (2027-2032) & (US$/unit) Table 62. Trillium Therapeutics Inc Company Information Table 63. Trillium Therapeutics Inc Business Overview Table 64. Trillium Therapeutics Inc Leukocyte Surface Antigen CD47 Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 65. Trillium Therapeutics Inc Leukocyte Surface Antigen CD47 Product Portfolio Table 66. Trillium Therapeutics Inc Recent Development Table 67. Surface Oncology Inc Company Information Table 68. Surface Oncology Inc Business Overview Table 69. Surface Oncology Inc Leukocyte Surface Antigen CD47 Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 70. Surface Oncology Inc Leukocyte Surface Antigen CD47 Product Portfolio Table 71. Surface Oncology Inc Recent Development Table 72. Forty Seven Inc Company Information Table 73. Forty Seven Inc Business Overview Table 74. Forty Seven Inc Leukocyte Surface Antigen CD47 Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 75. Forty Seven Inc Leukocyte Surface Antigen CD47 Product Portfolio Table 76. Forty Seven Inc Recent Development Table 77. Celgene Corp Company Information Table 78. Celgene Corp Business Overview Table 79. Celgene Corp Leukocyte Surface Antigen CD47 Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 80. Celgene Corp Leukocyte Surface Antigen CD47 Product Portfolio Table 81. Celgene Corp Recent Development Table 82. Aurigene Discovery Technologies Ltd Company Information Table 83. Aurigene Discovery Technologies Ltd Business Overview Table 84. Aurigene Discovery Technologies Ltd Leukocyte Surface Antigen CD47 Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 85. Aurigene Discovery Technologies Ltd Leukocyte Surface Antigen CD47 Product Portfolio Table 86. Aurigene Discovery Technologies Ltd Recent Development Table 87. North America Leukocyte Surface Antigen CD47 Revenue by Type (2021-2026) & (US$ Million) Table 88. North America Leukocyte Surface Antigen CD47 Revenue by Type (2027-2032) & (US$ Million) Table 89. North America Leukocyte Surface Antigen CD47 Sales by Type (2021-2026) & (k units) Table 90. North America Leukocyte Surface Antigen CD47 Sales by Type (2027-2032) & (k units) Table 91. North America Leukocyte Surface Antigen CD47 Sales Price by Type (2021-2026) & (US$/unit) Table 92. North America Leukocyte Surface Antigen CD47 Sales Price by Type (2027-2032) & (US$/unit) Table 93. North America Leukocyte Surface Antigen CD47 Revenue by Application (2021-2026) & (US$ Million) Table 94. North America Leukocyte Surface Antigen CD47 Revenue by Application (2027-2032) & (US$ Million) Table 95. North America Leukocyte Surface Antigen CD47 Sales by Application (2021-2026) & (k units) Table 96. North America Leukocyte Surface Antigen CD47 Sales by Application (2027-2032) & (k units) Table 97. North America Leukocyte Surface Antigen CD47 Sales Price by Application (2021-2026) & (US$/unit) Table 98. North America Leukocyte Surface Antigen CD47 Sales Price by Application (2027-2032) & (US$/unit) Table 99. North America Leukocyte Surface Antigen CD47 Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 100. North America Leukocyte Surface Antigen CD47 Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 101. North America Leukocyte Surface Antigen CD47 Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 102. North America Leukocyte Surface Antigen CD47 Sales by Country (2021 VS 2025 VS 2032) & (k units) Table 103. North America Leukocyte Surface Antigen CD47 Sales by Country (2021-2026) & (k units) Table 104. North America Leukocyte Surface Antigen CD47 Sales by Country (2027-2032) & (k units) Table 105. North America Leukocyte Surface Antigen CD47 Sales Price by Country (2021-2026) & (US$/unit) Table 106. North America Leukocyte Surface Antigen CD47 Sales Price by Country (2027-2032) & (US$/unit) Table 107. United States Leukocyte Surface Antigen CD47 Revenue (2021-2032) & (US$ Million) Table 108. Canada Leukocyte Surface Antigen CD47 Revenue (2021-2032) & (US$ Million) Table 109. Mexico Leukocyte Surface Antigen CD47 Revenue (2021-2032) & (US$ Million) Table 110. Europe Leukocyte Surface Antigen CD47 Revenue by Type (2021-2026) & (US$ Million) Table 111. Europe Leukocyte Surface Antigen CD47 Revenue by Type (2027-2032) & (US$ Million) Table 112. Europe Leukocyte Surface Antigen CD47 Sales by Type (2021-2026) & (k units) Table 113. Europe Leukocyte Surface Antigen CD47 Sales by Type (2027-2032) & (k units) Table 114. Europe Leukocyte Surface Antigen CD47 Sales Price by Type (2021-2026) & (US$/unit) Table 115. Europe Leukocyte Surface Antigen CD47 Sales Price by Type (2027-2032) & (US$/unit) Table 116. Europe Leukocyte Surface Antigen CD47 Revenue by Application (2021-2026) & (US$ Million) Table 117. Europe Leukocyte Surface Antigen CD47 Revenue by Application (2027-2032) & (US$ Million) Table 118. Europe Leukocyte Surface Antigen CD47 Sales by Application (2021-2026) & (k units) Table 119. Europe Leukocyte Surface Antigen CD47 Sales by Application (2027-2032) & (k units) Table 120. Europe Leukocyte Surface Antigen CD47 Sales Price by Application (2021-2026) & (US$/unit) Table 121. Europe Leukocyte Surface Antigen CD47 Sales Price by Application (2027-2032) & (US$/unit) Table 122. Europe Leukocyte Surface Antigen CD47 Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 123. Europe Leukocyte Surface Antigen CD47 Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 124. Europe Leukocyte Surface Antigen CD47 Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 125. Europe Leukocyte Surface Antigen CD47 Sales by Country (2021 VS 2025 VS 2032) & (k units) Table 126. Europe Leukocyte Surface Antigen CD47 Sales by Country (2021-2026) & (k units) Table 127. Europe Leukocyte Surface Antigen CD47 Sales by Country (2027-2032) & (k units) Table 128. Europe Leukocyte Surface Antigen CD47 Sales Price by Country (2021-2026) & (US$/unit) Table 129. Europe Leukocyte Surface Antigen CD47 Sales Price by Country (2027-2032) & (US$/unit) Table 130. Germany Leukocyte Surface Antigen CD47 Revenue (2021-2032) & (US$ Million) Table 131. France Leukocyte Surface Antigen CD47 Revenue (2021-2032) & (US$ Million) Table 132. U.K. Leukocyte Surface Antigen CD47 Revenue (2021-2032) & (US$ Million) Table 133. Italy Leukocyte Surface Antigen CD47 Revenue (2021-2032) & (US$ Million) Table 134. Russia Leukocyte Surface Antigen CD47 Revenue (2021-2032) & (US$ Million) Table 135. Spain Leukocyte Surface Antigen CD47 Revenue (2021-2032) & (US$ Million) Table 136. Netherlands Leukocyte Surface Antigen CD47 Revenue (2021-2032) & (US$ Million) Table 137. Switzerland Leukocyte Surface Antigen CD47 Revenue (2021-2032) & (US$ Million) Table 138. Sweden Leukocyte Surface Antigen CD47 Revenue (2021-2032) & (US$ Million) Table 139. Poland Leukocyte Surface Antigen CD47 Revenue (2021-2032) & (US$ Million) Table 140. China Leukocyte Surface Antigen CD47 Revenue by Type (2021-2026) & (US$ Million) Table 141. China Leukocyte Surface Antigen CD47 Revenue by Type (2027-2032) & (US$ Million) Table 142. China Leukocyte Surface Antigen CD47 Sales by Type (2021-2026) & (k units) Table 143. China Leukocyte Surface Antigen CD47 Sales by Type (2027-2032) & (k units) Table 144. China Leukocyte Surface Antigen CD47 Sales Price by Type (2021-2026) & (US$/unit) Table 145. China Leukocyte Surface Antigen CD47 Sales Price by Type (2027-2032) & (US$/unit) Table 146. China Leukocyte Surface Antigen CD47 Revenue by Application (2021-2026) & (US$ Million) Table 147. China Leukocyte Surface Antigen CD47 Revenue by Application (2027-2032) & (US$ Million) Table 148. China Leukocyte Surface Antigen CD47 Sales by Application (2021-2026) & (k units) Table 149. China Leukocyte Surface Antigen CD47 Sales by Application (2027-2032) & (k units) Table 150. China Leukocyte Surface Antigen CD47 Sales Price by Application (2021-2026) & (US$/unit) Table 151. China Leukocyte Surface Antigen CD47 Sales Price by Application (2027-2032) & (US$/unit) Table 152. Asia Leukocyte Surface Antigen CD47 Revenue by Type (2021-2026) & (US$ Million) Table 153. Asia Leukocyte Surface Antigen CD47 Revenue by Type (2027-2032) & (US$ Million) Table 154. Asia Leukocyte Surface Antigen CD47 Sales by Type (2021-2026) & (k units) Table 155. Asia Leukocyte Surface Antigen CD47 Sales by Type (2027-2032) & (k units) Table 156. Asia Leukocyte Surface Antigen CD47 Sales Price by Type (2021-2026) & (US$/unit) Table 157. Asia Leukocyte Surface Antigen CD47 Sales Price by Type (2027-2032) & (US$/unit) Table 158. Asia Leukocyte Surface Antigen CD47 Revenue by Application (2021-2026) & (US$ Million) Table 159. Asia Leukocyte Surface Antigen CD47 Revenue by Application (2027-2032) & (US$ Million) Table 160. Asia Leukocyte Surface Antigen CD47 Sales by Application (2021-2026) & (k units) Table 161. Asia Leukocyte Surface Antigen CD47 Sales by Application (2027-2032) & (k units) Table 162. Asia Leukocyte Surface Antigen CD47 Sales Price by Application (2021-2026) & (US$/unit) Table 163. Asia Leukocyte Surface Antigen CD47 Sales Price by Application (2027-2032) & (US$/unit) Table 164. Asia Leukocyte Surface Antigen CD47 Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 165. Asia Leukocyte Surface Antigen CD47 Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 166. Asia Leukocyte Surface Antigen CD47 Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 167. Asia Leukocyte Surface Antigen CD47 Sales by Country (2021 VS 2025 VS 2032) & (k units) Table 168. Asia Leukocyte Surface Antigen CD47 Sales by Country (2021-2026) & (k units) Table 169. Asia Leukocyte Surface Antigen CD47 Sales by Country (2027-2032) & (k units) Table 170. Asia Leukocyte Surface Antigen CD47 Sales Price by Country (2021-2026) & (US$/unit) Table 171. Asia Leukocyte Surface Antigen CD47 Sales Price by Country (2027-2032) & (US$/unit) Table 172. Japan Leukocyte Surface Antigen CD47 Revenue (2021-2032) & (US$ Million) Table 173. South Korea Leukocyte Surface Antigen CD47 Revenue (2021-2032) & (US$ Million) Table 174. India Leukocyte Surface Antigen CD47 Revenue (2021-2032) & (US$ Million) Table 175. Australia Leukocyte Surface Antigen CD47 Revenue (2021-2032) & (US$ Million) Table 176. Taiwan Leukocyte Surface Antigen CD47 Revenue (2021-2032) & (US$ Million) Table 177. Southeast Asia Leukocyte Surface Antigen CD47 Revenue (2021-2032) & (US$ Million) Table 178. SAMEA Leukocyte Surface Antigen CD47 Revenue by Type (2021-2026) & (US$ Million) Table 179. SAMEA Leukocyte Surface Antigen CD47 Revenue by Type (2027-2032) & (US$ Million) Table 180. SAMEA Leukocyte Surface Antigen CD47 Sales by Type (2021-2026) & (k units) Table 181. SAMEA Leukocyte Surface Antigen CD47 Sales by Type (2027-2032) & (k units) Table 182. SAMEA Leukocyte Surface Antigen CD47 Sales Price by Type (2021-2026) & (US$/unit) Table 183. SAMEA Leukocyte Surface Antigen CD47 Sales Price by Type (2027-2032) & (US$/unit) Table 184. SAMEA Leukocyte Surface Antigen CD47 Revenue by Application (2021-2026) & (US$ Million) Table 185. SAMEA Leukocyte Surface Antigen CD47 Revenue by Application (2027-2032) & (US$ Million) Table 186. SAMEA Leukocyte Surface Antigen CD47 Sales by Application (2021-2026) & (k units) Table 187. SAMEA Leukocyte Surface Antigen CD47 Sales by Application (2027-2032) & (k units) Table 188. SAMEA Leukocyte Surface Antigen CD47 Sales Price by Application (2021-2026) & (US$/unit) Table 189. SAMEA Leukocyte Surface Antigen CD47 Sales Price by Application (2027-2032) & (US$/unit) Table 190. SAMEA Leukocyte Surface Antigen CD47 Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 191. SAMEA Leukocyte Surface Antigen CD47 Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 192. SAMEA Leukocyte Surface Antigen CD47 Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 193. SAMEA Leukocyte Surface Antigen CD47 Sales by Country (2021 VS 2025 VS 2032) & (k units) Table 194. SAMEA Leukocyte Surface Antigen CD47 Sales by Country (2021-2026) & (k units) Table 195. SAMEA Leukocyte Surface Antigen CD47 Sales by Country (2027-2032) & (k units) Table 196. SAMEA Leukocyte Surface Antigen CD47 Sales Price by Country (2021-2026) & (US$/unit) Table 197. SAMEA Leukocyte Surface Antigen CD47 Sales Price by Country (2027-2032) & (US$/unit) Table 198. Brazil Leukocyte Surface Antigen CD47 Revenue (2021-2032) & (US$ Million) Table 199. Argentina Leukocyte Surface Antigen CD47 Revenue (2021-2032) & (US$ Million) Table 200. Chile Leukocyte Surface Antigen CD47 Revenue (2021-2032) & (US$ Million) Table 201. Colombia Leukocyte Surface Antigen CD47 Revenue (2021-2032) & (US$ Million) Table 202. Peru Leukocyte Surface Antigen CD47 Revenue (2021-2032) & (US$ Million) Table 203. Saudi Arabia Leukocyte Surface Antigen CD47 Revenue (2021-2032) & (US$ Million) Table 204. Israel Leukocyte Surface Antigen CD47 Revenue (2021-2032) & (US$ Million) Table 205. UAE Leukocyte Surface Antigen CD47 Revenue (2021-2032) & (US$ Million) Table 206. Turkey Leukocyte Surface Antigen CD47 Revenue (2021-2032) & (US$ Million) Table 207. Iran Leukocyte Surface Antigen CD47 Revenue (2021-2032) & (US$ Million) Table 208. Egypt Leukocyte Surface Antigen CD47 Revenue (2021-2032) & (US$ Million) Table 209. Key Raw Materials Table 210. Raw Materials Key Suppliers Table 211. Leukocyte Surface Antigen CD47 Distributors List Table 212. Leukocyte Surface Antigen CD47 Customers List Table 213. Research Programs/Design for This Report Table 214. Authors List of This Report Table 215. Secondary Sources Table 216. Primary Sources List of Figures Figure 1. Leukocyte Surface Antigen CD47 Image Figure 2. Global Leukocyte Surface Antigen CD47 Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Leukocyte Surface Antigen CD47 Market Size Share 2021 VS 2025 VS 2032 Figure 4. PSTx-23 Image Figure 5. CC-90002 Image Figure 6. B-6H12 Image Figure 7. ALX-148 Image Figure 8. Others Image Figure 9. Global Leukocyte Surface Antigen CD47 Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 10. Global Leukocyte Surface Antigen CD47 Market Size Share 2021 VS 2025 VS 2032 Figure 11. Ischemia Reperfusion Injury Image Figure 12. Kindney Transplant Rejection Image Figure 13. Ovarian Cancer Image Figure 14. Lymphoma Image Figure 15. Others Image Figure 16. Global Leukocyte Surface Antigen CD47 Revenue (US$ Million), 2021 VS 2025 VS 2032 Figure 17. Global Leukocyte Surface Antigen CD47 Revenue (2021-2032) & (US$ Million) Figure 18. Global Leukocyte Surface Antigen CD47 Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 19. Global Leukocyte Surface Antigen CD47 Revenue Market Share by Region: 2025 Versus 2032 Figure 20. Global Leukocyte Surface Antigen CD47 Revenue Market Share by Region (2021-2032) Figure 21. Global Leukocyte Surface Antigen CD47 Sales (2021-2032) & (k units) Figure 22. Global Leukocyte Surface Antigen CD47 Sales by Region: 2021 VS 2025 VS 2032 (k units) Figure 23. Global Leukocyte Surface Antigen CD47 Sales Market Share by Region (2021-2032) Figure 24. US & Canada & Mexico Leukocyte Surface Antigen CD47 Sales YoY (2021-2032) & (k units) Figure 25. Europe Leukocyte Surface Antigen CD47 Sales YoY (2021-2032) & (k units) Figure 26. China Leukocyte Surface Antigen CD47 Sales YoY (2021-2032) & (k units) Figure 27. Asia (Excluding China) Leukocyte Surface Antigen CD47 Sales YoY (2021-2032) & (k units) Figure 28. South America, Middle East and Africa Leukocyte Surface Antigen CD47 Sales YoY (2021-2032) & (k units) Figure 29. Global Leukocyte Surface Antigen CD47 Manufacturers Revenue Share Top 10 and Top 5 in 2025 Figure 30. Global Leukocyte Surface Antigen CD47 Manufacturers Sales Share Top 10 and Top 5 in 2025 Figure 31. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 32. Global Leukocyte Surface Antigen CD47 Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 33. Global Leukocyte Surface Antigen CD47 Revenue Market Share by Type 2021 VS 2025 VS 2032 Figure 34. Global Leukocyte Surface Antigen CD47 Revenue Market Share by Type (2021-2032) Figure 35. Global Leukocyte Surface Antigen CD47 Sales by Type (2021 VS 2025 VS 2032) & (k units) Figure 36. Global Leukocyte Surface Antigen CD47 Sales Market Share by Type 2021 VS 2025 VS 2032 Figure 37. Global Leukocyte Surface Antigen CD47 Sales Market Share by Type (2021-2032) Figure 38. Global Leukocyte Surface Antigen CD47 Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 39. Global Leukocyte Surface Antigen CD47 Revenue Market Share by Application 2021 VS 2025 VS 2032 Figure 40. Global Leukocyte Surface Antigen CD47 Revenue Market Share by Application (2021-2032) Figure 41. Global Leukocyte Surface Antigen CD47 Sales by Application (2021 VS 2025 VS 2032) & (k units) Figure 42. Global Leukocyte Surface Antigen CD47 Sales Market Share by Application 2021 VS 2025 VS 2032 Figure 43. Global Leukocyte Surface Antigen CD47 Sales Market Share by Application (2021-2032) Figure 44. North America Leukocyte Surface Antigen CD47 Revenue Share by Type (2021-2032) Figure 45. North America Leukocyte Surface Antigen CD47 Sales Share by Type (2021-2032) Figure 46. North America Leukocyte Surface Antigen CD47 Revenue Share by Application (2021-2032) Figure 47. North America Leukocyte Surface Antigen CD47 Sales Share by Application (2021-2032) Figure 48. North America Leukocyte Surface Antigen CD47 Revenue Share by Country (2021-2032) Figure 49. North America Leukocyte Surface Antigen CD47 Sales Share by Country (2021-2032) Figure 50. Europe Leukocyte Surface Antigen CD47 Revenue Share by Type (2021-2032) Figure 51. Europe Leukocyte Surface Antigen CD47 Sales Share by Type (2021-2032) Figure 52. Europe Leukocyte Surface Antigen CD47 Revenue Share by Application (2021-2032) Figure 53. Europe Leukocyte Surface Antigen CD47 Sales Share by Application (2021-2032) Figure 54. Europe Leukocyte Surface Antigen CD47 Revenue Share by Country (2021-2032) Figure 55. Europe Leukocyte Surface Antigen CD47 Sales Share by Country (2021-2032) Figure 56. China Leukocyte Surface Antigen CD47 Revenue Share by Type (2021-2032) Figure 57. China Leukocyte Surface Antigen CD47 Sales Share by Type (2021-2032) Figure 58. China Leukocyte Surface Antigen CD47 Revenue Share by Application (2021-2032) Figure 59. China Leukocyte Surface Antigen CD47 Sales Share by Application (2021-2032) Figure 60. Asia Leukocyte Surface Antigen CD47 Revenue Share by Type (2021-2032) Figure 61. Asia Leukocyte Surface Antigen CD47 Sales Share by Type (2021-2032) Figure 62. Asia Leukocyte Surface Antigen CD47 Revenue Share by Application (2021-2032) Figure 63. Asia Leukocyte Surface Antigen CD47 Sales Share by Application (2021-2032) Figure 64. Asia Leukocyte Surface Antigen CD47 Revenue Share by Country (2021-2032) Figure 65. Asia Leukocyte Surface Antigen CD47 Sales Share by Country (2021-2032) Figure 66. SAMEA Leukocyte Surface Antigen CD47 Revenue Share by Type (2021-2032) Figure 67. SAMEA Leukocyte Surface Antigen CD47 Sales Share by Type (2021-2032) Figure 68. SAMEA Leukocyte Surface Antigen CD47 Revenue Share by Application (2021-2032) Figure 69. SAMEA Leukocyte Surface Antigen CD47 Sales Share by Application (2021-2032) Figure 70. SAMEA Leukocyte Surface Antigen CD47 Revenue Share by Country (2021-2032) Figure 71. SAMEA Leukocyte Surface Antigen CD47 Sales Share by Country (2021-2032) Figure 72. Leukocyte Surface Antigen CD47 Value Chain Figure 73. Manufacturing Cost Structure Figure 74. Leukocyte Surface Antigen CD47 Production Mode & Process Figure 75. Direct Comparison with Distribution Share Figure 76. Distributors Profiles Figure 77. Years Considered Figure 78. Research Process Figure 79. Key Executives Interviewed

Scope & coverage.

Types
  • PSTx-23
  • CC-90002
  • B-6H12
  • ALX-148
  • Others
Applications
  • Ischemia Reperfusion Injury
  • Kindney Transplant Rejection
  • Ovarian Cancer
  • Lymphoma
  • Others
Companies covered
  • Trillium Therapeutics Inc
  • Surface Oncology Inc
  • Forty Seven Inc
  • Celgene Corp
  • Aurigene Discovery Technologies Ltd

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Leukocyte Surface Antigen CD47 Market by Type
  3. 1.2.1 Global Leukocyte Surface Antigen CD47 Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 PSTx-23
  5. 1.2.3 CC-90002
  6. 1.2.4 B-6H12
  7. 1.2.5 ALX-148
  8. 1.2.6 Others
  9. 1.3 Leukocyte Surface Antigen CD47 Market by Application
  10. 1.3.1 Global Leukocyte Surface Antigen CD47 Market Size by Application, 2021 VS 2025 VS 2032
  11. 1.3.2 Ischemia Reperfusion Injury
  12. 1.3.3 Kindney Transplant Rejection
  13. 1.3.4 Ovarian Cancer
  14. 1.3.5 Lymphoma
  15. 1.3.6 Others
  16. 1.4 Assumptions and Limitations
  17. 1.5 Study Goals and Objectives
2 Leukocyte Surface Antigen CD47 Market Dynamics
  1. 2.1 Leukocyte Surface Antigen CD47 Industry Trends
  2. 2.2 Leukocyte Surface Antigen CD47 Industry Drivers
  3. 2.3 Leukocyte Surface Antigen CD47 Industry Opportunities and Challenges
  4. 2.4 Leukocyte Surface Antigen CD47 Industry Restraints
3 Global Market Growth Prospects
  1. 3.1 Global Leukocyte Surface Antigen CD47 Revenue Estimates and Forecasts (2021-2032)
  2. 3.2 Global Leukocyte Surface Antigen CD47 Revenue by Region
  3. 3.2.1 Global Leukocyte Surface Antigen CD47 Revenue by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global Leukocyte Surface Antigen CD47 Revenue by Region (2021-2026)
  5. 3.2.3 Global Leukocyte Surface Antigen CD47 Revenue by Region (2027-2032)
  6. 3.2.4 Global Leukocyte Surface Antigen CD47 Revenue Market Share by Region (2021-2032)
  7. 3.3 Global Leukocyte Surface Antigen CD47 Sales Estimates and Forecasts 2021-2032
  8. 3.4 Global Leukocyte Surface Antigen CD47 Sales by Region
  9. 3.4.1 Global Leukocyte Surface Antigen CD47 Sales by Region: 2021 VS 2025 VS 2032
  10. 3.4.2 Global Leukocyte Surface Antigen CD47 Sales by Region (2021-2026)
  11. 3.4.3 Global Leukocyte Surface Antigen CD47 Sales by Region (2027-2032)
  12. 3.4.4 Global Leukocyte Surface Antigen CD47 Sales Market Share by Region (2021-2032)
  13. 3.5 US & Canada & Mexico
  14. 3.6 Europe
  15. 3.7 China
  16. 3.8 Asia (Excluding China)
  17. 3.9 South America, Middle East and Africa
4 Market Competitive Landscape by Manufacturers
  1. 4.1 Global Leukocyte Surface Antigen CD47 Revenue by Manufacturers
  2. 4.1.1 Global Leukocyte Surface Antigen CD47 Revenue by Manufacturers (2021-2026)
  3. 4.1.2 Global Leukocyte Surface Antigen CD47 Revenue Market Share by Manufacturers (2021-2026)
  4. 4.1.3 Global Leukocyte Surface Antigen CD47 Manufacturers Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global Leukocyte Surface Antigen CD47 Sales by Manufacturers
  6. 4.2.1 Global Leukocyte Surface Antigen CD47 Sales by Manufacturers (2021-2026)
  7. 4.2.2 Global Leukocyte Surface Antigen CD47 Sales Market Share by Manufacturers (2021-2026)
  8. 4.2.3 Global Leukocyte Surface Antigen CD47 Manufacturers Sales Share Top 10 and Top 5 in 2025
  9. 4.3 Global Leukocyte Surface Antigen CD47 Sales Price by Manufacturers (2021-2026)
  10. 4.4 Global Leukocyte Surface Antigen CD47 Key Manufacturers Ranking, 2024 VS 2025 VS 2026
  11. 4.5 Global Leukocyte Surface Antigen CD47 Key Manufacturers Manufacturing Sites & Headquarters
  12. 4.6 Global Leukocyte Surface Antigen CD47 Manufacturers, Product Type & Application
  13. 4.7 Global Leukocyte Surface Antigen CD47 Manufacturers' Establishment Date
  14. 4.8 Market Competitive Analysis
  15. 4.8.1 Global Leukocyte Surface Antigen CD47 Market CR5 and HHI
  16. 4.8.2 2025 Leukocyte Surface Antigen CD47 Tier 1, Tier 2, and Tier 3
5 Leukocyte Surface Antigen CD47 Market by Type
  1. 5.1 Global Leukocyte Surface Antigen CD47 Revenue by Type
  2. 5.1.1 Global Leukocyte Surface Antigen CD47 Revenue by Type (2021 VS 2025 VS 2032)
  3. 5.1.2 Global Leukocyte Surface Antigen CD47 Revenue by Type (2021-2032) & (US$ Million)
  4. 5.1.3 Global Leukocyte Surface Antigen CD47 Revenue Market Share by Type (2021-2032)
  5. 5.2 Global Leukocyte Surface Antigen CD47 Sales by Type
  6. 5.2.1 Global Leukocyte Surface Antigen CD47 Sales by Type (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Leukocyte Surface Antigen CD47 Sales by Type (2021-2032) & (k units)
  8. 5.2.3 Global Leukocyte Surface Antigen CD47 Sales Market Share by Type (2021-2032)
  9. 5.3 Global Leukocyte Surface Antigen CD47 Price by Type
6 Leukocyte Surface Antigen CD47 Market by Application
  1. 6.1 Global Leukocyte Surface Antigen CD47 Revenue by Application
  2. 6.1.1 Global Leukocyte Surface Antigen CD47 Revenue by Application (2021 VS 2025 VS 2032)
  3. 6.1.2 Global Leukocyte Surface Antigen CD47 Revenue by Application (2021-2032) & (US$ Million)
  4. 6.1.3 Global Leukocyte Surface Antigen CD47 Revenue Market Share by Application (2021-2032)
  5. 6.2 Global Leukocyte Surface Antigen CD47 Sales by Application
  6. 6.2.1 Global Leukocyte Surface Antigen CD47 Sales by Application (2021 VS 2025 VS 2032)
  7. 6.2.2 Global Leukocyte Surface Antigen CD47 Sales by Application (2021-2032) & (k units)
  8. 6.2.3 Global Leukocyte Surface Antigen CD47 Sales Market Share by Application (2021-2032)
  9. 6.3 Global Leukocyte Surface Antigen CD47 Price by Application
7 Company Profiles
  1. 7.1 Trillium Therapeutics Inc
  2. 7.1.1 Trillium Therapeutics Inc Company Information
  3. 7.1.2 Trillium Therapeutics Inc Business Overview
  4. 7.1.3 Trillium Therapeutics Inc Leukocyte Surface Antigen CD47 Sales, Revenue, Price and Gross Margin (2021-2026)
  5. 7.1.4 Trillium Therapeutics Inc Leukocyte Surface Antigen CD47 Product Portfolio
  6. 7.1.5 Trillium Therapeutics Inc Recent Developments
  7. 7.2 Surface Oncology Inc
  8. 7.2.1 Surface Oncology Inc Company Information
  9. 7.2.2 Surface Oncology Inc Business Overview
  10. 7.2.3 Surface Oncology Inc Leukocyte Surface Antigen CD47 Sales, Revenue, Price and Gross Margin (2021-2026)
  11. 7.2.4 Surface Oncology Inc Leukocyte Surface Antigen CD47 Product Portfolio
  12. 7.2.5 Surface Oncology Inc Recent Developments
  13. 7.3 Forty Seven Inc
  14. 7.3.1 Forty Seven Inc Company Information
  15. 7.3.2 Forty Seven Inc Business Overview
  16. 7.3.3 Forty Seven Inc Leukocyte Surface Antigen CD47 Sales, Revenue, Price and Gross Margin (2021-2026)
  17. 7.3.4 Forty Seven Inc Leukocyte Surface Antigen CD47 Product Portfolio
  18. 7.3.5 Forty Seven Inc Recent Developments
  19. 7.4 Celgene Corp
  20. 7.4.1 Celgene Corp Company Information
  21. 7.4.2 Celgene Corp Business Overview
  22. 7.4.3 Celgene Corp Leukocyte Surface Antigen CD47 Sales, Revenue, Price and Gross Margin (2021-2026)
  23. 7.4.4 Celgene Corp Leukocyte Surface Antigen CD47 Product Portfolio
  24. 7.4.5 Celgene Corp Recent Developments
  25. 7.5 Aurigene Discovery Technologies Ltd
  26. 7.5.1 Aurigene Discovery Technologies Ltd Company Information
  27. 7.5.2 Aurigene Discovery Technologies Ltd Business Overview
  28. 7.5.3 Aurigene Discovery Technologies Ltd Leukocyte Surface Antigen CD47 Sales, Revenue, Price and Gross Margin (2021-2026)
  29. 7.5.4 Aurigene Discovery Technologies Ltd Leukocyte Surface Antigen CD47 Product Portfolio
  30. 7.5.5 Aurigene Discovery Technologies Ltd Recent Developments
8 North America
  1. 8.1 North America Leukocyte Surface Antigen CD47 Market Size by Type
  2. 8.1.1 North America Leukocyte Surface Antigen CD47 Revenue by Type (2021-2032)
  3. 8.1.2 North America Leukocyte Surface Antigen CD47 Sales by Type (2021-2032)
  4. 8.1.3 North America Leukocyte Surface Antigen CD47 Price by Type (2021-2032)
  5. 8.2 North America Leukocyte Surface Antigen CD47 Market Size by Application
  6. 8.2.1 North America Leukocyte Surface Antigen CD47 Revenue by Application (2021-2032)
  7. 8.2.2 North America Leukocyte Surface Antigen CD47 Sales by Application (2021-2032)
  8. 8.2.3 North America Leukocyte Surface Antigen CD47 Price by Application (2021-2032)
  9. 8.3 North America Leukocyte Surface Antigen CD47 Market Size by Country
  10. 8.3.1 North America Leukocyte Surface Antigen CD47 Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 8.3.2 North America Leukocyte Surface Antigen CD47 Sales by Country (2021 VS 2025 VS 2032)
  12. 8.3.3 North America Leukocyte Surface Antigen CD47 Price by Country (2021-2032)
  13. 8.3.4 United States
  14. 8.3.5 Canada
  15. 8.3.6 Mexico
9 Europe
  1. 9.1 Europe Leukocyte Surface Antigen CD47 Market Size by Type
  2. 9.1.1 Europe Leukocyte Surface Antigen CD47 Revenue by Type (2021-2032)
  3. 9.1.2 Europe Leukocyte Surface Antigen CD47 Sales by Type (2021-2032)
  4. 9.1.3 Europe Leukocyte Surface Antigen CD47 Price by Type (2021-2032)
  5. 9.2 Europe Leukocyte Surface Antigen CD47 Market Size by Application
  6. 9.2.1 Europe Leukocyte Surface Antigen CD47 Revenue by Application (2021-2032)
  7. 9.2.2 Europe Leukocyte Surface Antigen CD47 Sales by Application (2021-2032)
  8. 9.2.3 Europe Leukocyte Surface Antigen CD47 Price by Application (2021-2032)
  9. 9.3 Europe Leukocyte Surface Antigen CD47 Market Size by Country
  10. 9.3.1 Europe Leukocyte Surface Antigen CD47 Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 9.3.2 Europe Leukocyte Surface Antigen CD47 Sales by Country (2021 VS 2025 VS 2032)
  12. 9.3.3 Europe Leukocyte Surface Antigen CD47 Price by Country (2021-2032)
  13. 9.3.4 Germany
  14. 9.3.5 France
  15. 9.3.6 U.K.
  16. 9.3.7 Italy
  17. 9.3.8 Russia
  18. 9.3.9 Spain
  19. 9.3.10 Netherlands
10 China
  1. 10.1 China Leukocyte Surface Antigen CD47 Market Size by Type
  2. 10.1.1 China Leukocyte Surface Antigen CD47 Revenue by Type (2021-2032)
  3. 10.1.2 China Leukocyte Surface Antigen CD47 Sales by Type (2021-2032)
  4. 10.1.3 China Leukocyte Surface Antigen CD47 Price by Type (2021-2032)
  5. 10.2 China Leukocyte Surface Antigen CD47 Market Size by Application
  6. 10.2.1 China Leukocyte Surface Antigen CD47 Revenue by Application (2021-2032)
  7. 10.2.2 China Leukocyte Surface Antigen CD47 Sales by Application (2021-2032)
  8. 10.2.3 China Leukocyte Surface Antigen CD47 Price by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia Leukocyte Surface Antigen CD47 Market Size by Type
  2. 11.1.1 Asia Leukocyte Surface Antigen CD47 Revenue by Type (2021-2032)
  3. 11.1.2 Asia Leukocyte Surface Antigen CD47 Sales by Type (2021-2032)
  4. 11.1.3 Asia Leukocyte Surface Antigen CD47 Price by Type (2021-2032)
  5. 11.2 Asia Leukocyte Surface Antigen CD47 Market Size by Application
  6. 11.2.1 Asia Leukocyte Surface Antigen CD47 Revenue by Application (2021-2032)
  7. 11.2.2 Asia Leukocyte Surface Antigen CD47 Sales by Application (2021-2032)
  8. 11.2.3 Asia Leukocyte Surface Antigen CD47 Price by Application (2021-2032)
  9. 11.3 Asia Leukocyte Surface Antigen CD47 Market Size by Country
  10. 11.3.1 Asia Leukocyte Surface Antigen CD47 Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 11.3.2 Asia Leukocyte Surface Antigen CD47 Sales by Country (2021 VS 2025 VS 2032)
  12. 11.3.3 Asia Leukocyte Surface Antigen CD47 Price by Country (2021-2032)
  13. 11.3.4 Japan
  14. 11.3.5 South Korea
  15. 11.3.6 India
  16. 11.3.7 Australia
  17. 11.3.8 Taiwan
  18. 11.3.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA Leukocyte Surface Antigen CD47 Market Size by Type
  2. 12.1.1 SAMEA Leukocyte Surface Antigen CD47 Revenue by Type (2021-2032)
  3. 12.1.2 SAMEA Leukocyte Surface Antigen CD47 Sales by Type (2021-2032)
  4. 12.1.3 SAMEA Leukocyte Surface Antigen CD47 Price by Type (2021-2032)
  5. 12.2 SAMEA Leukocyte Surface Antigen CD47 Market Size by Application
  6. 12.2.1 SAMEA Leukocyte Surface Antigen CD47 Revenue by Application (2021-2032)
  7. 12.2.2 SAMEA Leukocyte Surface Antigen CD47 Sales by Application (2021-2032)
  8. 12.2.3 SAMEA Leukocyte Surface Antigen CD47 Price by Application (2021-2032)
  9. 12.3 SAMEA Leukocyte Surface Antigen CD47 Market Size by Country
  10. 12.3.1 SAMEA Leukocyte Surface Antigen CD47 Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 12.3.2 SAMEA Leukocyte Surface Antigen CD47 Sales by Country (2021 VS 2025 VS 2032)
  12. 12.3.3 SAMEA Leukocyte Surface Antigen CD47 Price by Country (2021-2032)
  13. 12.3.4 Brazil
  14. 12.3.5 Argentina
  15. 12.3.6 Chile
  16. 12.3.7 Colombia
  17. 12.3.8 Peru
  18. 12.3.9 Saudi Arabia
  19. 12.3.10 Israel
  20. 12.3.11 UAE
  21. 12.3.12 Turkey
  22. 12.3.13 Iran
  23. 12.3.14 Egypt
13 Value Chain and Sales Channels Analysis
  1. 13.1 Leukocyte Surface Antigen CD47 Value Chain Analysis
  2. 13.1.1 Leukocyte Surface Antigen CD47 Key Raw Materials
  3. 13.1.2 Raw Materials Key Suppliers
  4. 13.1.3 Manufacturing Cost Structure
  5. 13.1.4 Leukocyte Surface Antigen CD47 Production Mode & Process
  6. 13.2 Leukocyte Surface Antigen CD47 Sales Channels Analysis
  7. 13.2.1 Direct Comparison with Distribution Share
  8. 13.2.2 Leukocyte Surface Antigen CD47 Distributors
  9. 13.2.3 Leukocyte Surface Antigen CD47 Customers
14 Concluding Insights
    15 Appendix
    1. 15.1 Reasons for Doing This Study
    2. 15.2 Research Methodology
    3. 15.3 Research Process
    4. 15.4 Authors List of This Report
    5. 15.5 Data Source
    6. 15.5.1 Secondary Sources
    7. 15.5.2 Primary Sources
    8. 15.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst